Compare metabolites in 2 of these studies:
Study A:   Study B:  

List of Studies ( Metabolite:TG 17:1_18:1_20:1)

Study_idAnalysis_idStudy_titleSourceSpeciesDiseaseInstituteAnalysis Type
ST003988 AN006569 Lipid and cell cycling perturbations driven by the HDAC inhibitor romidepsin render liver cancer vulnerable to RTK targeting and immunologically active Cultured cells Human Cancer CNRS LC-MS
ST003717 AN006098 Lipidomics analysis of mouse pancreatic cancer cells cultured RPMI, TIFM, or TIFM + arginine under lipid deprivation Cultured cells Mouse Cancer University of Chicago LC-MS
ST003715 AN006096 Lipidomics analysis of mouse PDAC cell lines treated with tung oil Cultured cells Mouse Cancer University of Chicago LC-MS
ST003714 AN006095 Lipidomics analysis of mouse PDAC cell lines treated with alpha-eleostearic acid Cultured cells Mouse Cancer University of Chicago LC-MS
ST003637 AN005973 lomitapide effects on lipidomics Pancreas Human Cancer Pennsylvania State University LC-MS
ST003528 AN005795 Lipidomics profiling of livers from Alb-Cre +/- SART-/- (KO) versus age matched wild type WT mouse littermates to characterize progression to hepatic steatosis and hepatocellular carcinoma Liver Mouse Cancer University of Utah LC-MS
ST002414 AN003935 Mass spectrometry dataset of LC-MS Lipidomics Analysis of Xenopus Laevis Optic Nerve Eye tissue Frog Eye disease University of Miami LC-MS
ST001059 AN001733 Lipidomics for wildlife disease etiology and biomarker discovery: a case study of pansteatitis outbreak in South Africa (part-II) Adipose tissue Mozambique tilapia Inflammation South East Center for Integrated Metabolomics LC-MS
ST001052 AN001721 Lipidomics for wildlife disease etiology and biomarker discovery: a case study of pansteatitis outbreak in South Africa (part-I) Blood Mozambique tilapia Inflammation South East Center for Integrated Metabolomics LC-MS
  logo